Literature DB >> 3415095

Ruptured abdominal aortic aneurysm: a 25-year experience and analysis of recent cases.

R S Martin1, W H Edwards, J M Jenkins, W H Edwards, J L Mulherin.   

Abstract

An 8-year experience with treatment of 58 patients with ruptured abdominal aortic aneurysm (RAAA) is reviewed with hospital mortality of 25.9 per cent. Added to a previously reported experience, 115 patients have been treated over 25 years with 33 per cent mortality. Preoperative hypotension, free rupture, venous injury, and massive transfusion were found to be associated with mortality. Interhospital transfer, preexisting coronary or pulmonary disease, known aneurysm, anemia, delay in surgery, and operative time were not found to predict outcome. Some patients are normotensive at presentation, providing an excellent chance for survival when expeditious diagnosis and treatment are carried out. Optimal operative management, complications, and causes of death are discussed. The role of computed tomography (CT) in diagnosis is considered. Elective resection of known aneurysms is the most important factor in reducing deaths from RAAA. The role of regionalization of care is unclear, since some patients cannot be safely transported. However, some evidence for optimal results in specialized centers is presented.

Entities:  

Mesh:

Year:  1988        PMID: 3415095

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  A statewide, population-based time-series analysis of the outcome of ruptured abdominal aortic aneurysm.

Authors:  R Rutledge; D W Oller; A A Meyer; G J Johnson
Journal:  Ann Surg       Date:  1996-05       Impact factor: 12.969

Review 2.  Haemodynamic management in ruptured abdominal aortic aneurysm.

Authors:  J Brimacombe; A Berry
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

3.  Operative treatment of abdominal aortic aneurysms in octogenarians. When is it too much too late?

Authors:  R H Dean; J D Woody; C E Enarson; K J Hansen; G W Plonk
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.